Skip to main content
Erschienen in: Clinical Rheumatology 12/2020

23.05.2020 | Original Article

Cachexia in patients with rheumatoid arthritis: a cohort study

verfasst von: Rafaela CE Santo, Jordana MS Silva, Priscila S Lora, Ana Laura D Moro, Eduarda C Freitas, Bárbara J Bartikoski, Nicole PB Andrade, Penélope E Palominos, Vanessa Hax, Tayane M Fighera, Poli Mara Spritzer, Claiton V Brenol, Rafael MS Chakr, Lidiane I Filippin, Joshua F Baker, Ricardo M Xavier

Erschienen in: Clinical Rheumatology | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Rheumatoid arthritis (RA) is an inflammatory disease that leads to altered body composition. The loss of lean mass with a preservation or increase in fat mass has been termed rheumatoid cachexia (RC), to contrast with classic cachexia, which is characterized by severe weight loss. There are limited data on the prevalence and progression of cachexia in RA over time, as well as on associated factors. Our aim was to determine the prevalence of cachexia and to determine associations with potential factors.

Methods

This prospective cohort study recruited consecutively patients diagnosed with RA and followed for 1 year. The assessments were performed: clinical features, body composition, and physical function. RC and classic cachexia were assessed by several established diagnostic criteria. The pairwise Student’s t test, Chi-square test, and GEE were performed (accepted at p ≤ 0.05).

Results

Of 90 patients recruited, 81 completed the study. Most patients were women (88.9%), and the mean age was 56.5 ± 7.3 years. At baseline, the median DAS28-CRP was 3.0 (IQR, 1.0–3.0), 13.3–30.0% of the included patients had RC, while none met criteria for classic cachexia. The prevalence of cachexia did not change after 12 months. Disease activity status and treatment with biologic disease-modifying antirheumatic drugs were significantly associated with changes on body composition and physical function (p < 0.05).

Conclusions

In this cohort, RC was common, while classic cachexia was absent. Disease activity and use of biologic therapies were associated with changes on body composition and physical function, underscoring the importance of aiming for remission when treating RA.
Key Points
Rheumatoid cachexia is common in RA patients.
Classical cachexia is not often in RA patients.
Disease activity and use of biologic therapies are associated with changes on body composition and physical function.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
8.
Zurück zum Zitat Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H, Dawson-Hughes B, Dinarello CA, Rosenberg IH (1994) Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 93:2379–2386. https://doi.org/10.1172/JCI117244 Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H, Dawson-Hughes B, Dinarello CA, Rosenberg IH (1994) Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 93:2379–2386. https://​doi.​org/​10.​1172/​JCI117244
9.
Zurück zum Zitat Rall LC, Roubenoff R (2004) Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology. 43:1219–1223CrossRefPubMed Rall LC, Roubenoff R (2004) Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology. 43:1219–1223CrossRefPubMed
10.
Zurück zum Zitat Walsmith J, Abad L, Kehayias J, Roubenoff R (2004) Tumor necrosis factor-alpha production is associated with less body cell mass in women with rheumatoid arthritis. J Rheumatol 31:23–29PubMed Walsmith J, Abad L, Kehayias J, Roubenoff R (2004) Tumor necrosis factor-alpha production is associated with less body cell mass in women with rheumatoid arthritis. J Rheumatol 31:23–29PubMed
12.
13.
14.
Zurück zum Zitat Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P, Fearon KC, Laviano A, Maggio M, Fanelli FR, Schneider SM, Schols A, Sieber CC (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “ nutrition in geriatrics”. Clin Nutr 29:154–159. https://doi.org/10.1016/j.clnu.2009.12.004CrossRefPubMed Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P, Fearon KC, Laviano A, Maggio M, Fanelli FR, Schneider SM, Schols A, Sieber CC (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “ nutrition in geriatrics”. Clin Nutr 29:154–159. https://​doi.​org/​10.​1016/​j.​clnu.​2009.​12.​004CrossRefPubMed
16.
Zurück zum Zitat Elkan A-C, Hakansson N, Frostegard J, Cederholm T, Hafstrom I (2009) Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 11:R37. https://doi.org/10.1186/ar2643CrossRefPubMedPubMedCentral Elkan A-C, Hakansson N, Frostegard J, Cederholm T, Hafstrom I (2009) Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 11:R37. https://​doi.​org/​10.​1186/​ar2643CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Metsios GS, Stavropoulos-Kalinoglou A, Panoulas VF, Sandoo A, Toms TE, Nevill AM, Koutedakis Y, Kitas GD (2009) Rheumatoid cachexia and cardiovascular disease. Clin Exp Rheumatol 27:985–988 Metsios GS, Stavropoulos-Kalinoglou A, Panoulas VF, Sandoo A, Toms TE, Nevill AM, Koutedakis Y, Kitas GD (2009) Rheumatoid cachexia and cardiovascular disease. Clin Exp Rheumatol 27:985–988
19.
Zurück zum Zitat Hugo M, Cetre NM, Pierreisnard A, Schaeverbeke T, Gin H, Rigalleau V (2016) Energy expenditure and nutritional complications of metabolic syndrome and rheumatoid cachexia in rheumatoid arthritis: an observational study using calorimetry and actimetry. Rheumatol. 55:1202–1209. https://doi.org/10.1093/rheumatology/kew038CrossRef Hugo M, Cetre NM, Pierreisnard A, Schaeverbeke T, Gin H, Rigalleau V (2016) Energy expenditure and nutritional complications of metabolic syndrome and rheumatoid cachexia in rheumatoid arthritis: an observational study using calorimetry and actimetry. Rheumatol. 55:1202–1209. https://​doi.​org/​10.​1093/​rheumatology/​kew038CrossRef
20.
24.
Zurück zum Zitat Bruce B, Fries JF (2005) The health assessment questionnaire (HAQ). Clin Exp Rheumatol 23:S14–S18PubMed Bruce B, Fries JF (2005) The health assessment questionnaire (HAQ). Clin Exp Rheumatol 23:S14–S18PubMed
26.
Zurück zum Zitat Schutz Y, Kyle UUG, Pichard C (2002) Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98 y. Int J Obes Relat Metab Disord 26:953–960CrossRefPubMed Schutz Y, Kyle UUG, Pichard C (2002) Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98 y. Int J Obes Relat Metab Disord 26:953–960CrossRefPubMed
30.
Zurück zum Zitat Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J (2005) Validation of the functional assessment of chronic illness therapy fatigue scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 32:811–819PubMed Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J (2005) Validation of the functional assessment of chronic illness therapy fatigue scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 32:811–819PubMed
31.
Zurück zum Zitat Chang VT, Xia Q, Kasimis B (2005) The functional assessment of anorexia/cachexia therapy (FAACT) appetite scale in veteran cancer patients. J Support Oncol 3:377–382PubMed Chang VT, Xia Q, Kasimis B (2005) The functional assessment of anorexia/cachexia therapy (FAACT) appetite scale in veteran cancer patients. J Support Oncol 3:377–382PubMed
35.
Zurück zum Zitat Marcora SM, Chester KR, Mittal G, Lemmey AB, Maddison PJ (2006) Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr 84:1463–1472CrossRefPubMed Marcora SM, Chester KR, Mittal G, Lemmey AB, Maddison PJ (2006) Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr 84:1463–1472CrossRefPubMed
37.
Zurück zum Zitat Stavropoulos-Kalinoglou A, Metsios GS, Smith JP, Panoulas VF, Douglas KMJ, Jamurtas AZ, Koutedakis Y, Kitas GD (2010) What predicts obesity in patients with rheumatoid arthritis an investigation of the interactions between lifestyle and inflammation. Int J Obes 34:295–301. https://doi.org/10.1038/ijo.2009.220CrossRef Stavropoulos-Kalinoglou A, Metsios GS, Smith JP, Panoulas VF, Douglas KMJ, Jamurtas AZ, Koutedakis Y, Kitas GD (2010) What predicts obesity in patients with rheumatoid arthritis an investigation of the interactions between lifestyle and inflammation. Int J Obes 34:295–301. https://​doi.​org/​10.​1038/​ijo.​2009.​220CrossRef
38.
Zurück zum Zitat Baker JF, Sauer BC, Cannon GW, Teng C-C, Michaud K, Ibrahim S, Jorgenson E, Davis L, Caplan L, Cannella A, Mikuls TR (2016) Changes in body mass related to the initiation of disease-modifying therapies in rheumatoid arthritis. Arthritis Rheum 68:1818–1827. https://doi.org/10.1002/art.39647CrossRef Baker JF, Sauer BC, Cannon GW, Teng C-C, Michaud K, Ibrahim S, Jorgenson E, Davis L, Caplan L, Cannella A, Mikuls TR (2016) Changes in body mass related to the initiation of disease-modifying therapies in rheumatoid arthritis. Arthritis Rheum 68:1818–1827. https://​doi.​org/​10.​1002/​art.​39647CrossRef
39.
Zurück zum Zitat Jurgens MS, Jacobs JWG, Geenen R, Bossema ER, Bakker MF, Bijlsma JWJ, van Albada-Kuipers IA, Ehrlich JC, Lafeber FPJG, Welsing PMJ, on behalf of The Utrecht Arthritis Cohort Study Group (2013) Increase of body mass index in a tight controlled methotrexate-based strategy with prednisone in early rheumatoid arthritis: side effect of the prednisone or better control of disease activity? Arthritis Care Res 65:88–93. https://doi.org/10.1002/acr.21797CrossRef Jurgens MS, Jacobs JWG, Geenen R, Bossema ER, Bakker MF, Bijlsma JWJ, van Albada-Kuipers IA, Ehrlich JC, Lafeber FPJG, Welsing PMJ, on behalf of The Utrecht Arthritis Cohort Study Group (2013) Increase of body mass index in a tight controlled methotrexate-based strategy with prednisone in early rheumatoid arthritis: side effect of the prednisone or better control of disease activity? Arthritis Care Res 65:88–93. https://​doi.​org/​10.​1002/​acr.​21797CrossRef
40.
Zurück zum Zitat Popescu C, Bojincă V, Opriş D, Ionescu R (2015) Dual X-ray absorptiometry whole body composition of adipose tissue in rheumatoid arthritis. Rom J Intern Med 53:1–11 Popescu C, Bojincă V, Opriş D, Ionescu R (2015) Dual X-ray absorptiometry whole body composition of adipose tissue in rheumatoid arthritis. Rom J Intern Med 53:1–11
Metadaten
Titel
Cachexia in patients with rheumatoid arthritis: a cohort study
verfasst von
Rafaela CE Santo
Jordana MS Silva
Priscila S Lora
Ana Laura D Moro
Eduarda C Freitas
Bárbara J Bartikoski
Nicole PB Andrade
Penélope E Palominos
Vanessa Hax
Tayane M Fighera
Poli Mara Spritzer
Claiton V Brenol
Rafael MS Chakr
Lidiane I Filippin
Joshua F Baker
Ricardo M Xavier
Publikationsdatum
23.05.2020
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 12/2020
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05119-y

Weitere Artikel der Ausgabe 12/2020

Clinical Rheumatology 12/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.